180 related articles for article (PubMed ID: 22457015)
1. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.
Smith WB; Marbury TC; Komjathy SF; Sumeray MS; Williams GC; Hu MY; Mould DR
Eur J Clin Pharmacol; 2012 Oct; 68(10):1385-94. PubMed ID: 22457015
[TBL] [Abstract][Full Text] [Related]
2. Clevidipine: a review of its use in the management of acute hypertension.
Deeks ED; Keating GM; Keam SJ
Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.
Ericsson H; Fakt C; Jolin-Mellgård A; Nordlander M; Sohtell L; Sunzel M; Regårdh CG
Br J Clin Pharmacol; 1999 May; 47(5):531-8. PubMed ID: 10336577
[TBL] [Abstract][Full Text] [Related]
4. Clevidipine in adult cardiac surgical patients: a dose-finding study.
Bailey JM; Lu W; Levy JH; Ramsay JG; Shore-Lesserson L; Prielipp RC; Brister NW; Roach GW; Jolin-Mellgard A; Nordlander M
Anesthesiology; 2002 May; 96(5):1086-94. PubMed ID: 11981147
[TBL] [Abstract][Full Text] [Related]
5. Clevidipine for the treatment of severe hypertension in adults.
Nguyen HM; Ma K; Pham DQ
Clin Ther; 2010 Jan; 32(1):11-23. PubMed ID: 20171407
[TBL] [Abstract][Full Text] [Related]
6. Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis.
Frank Peacock W; Varon J; Ebrahimi R; Dunbar L; Pollack CV
Blood Press Suppl; 2011 Apr; 1(Suppl 1):20-5. PubMed ID: 21091269
[TBL] [Abstract][Full Text] [Related]
7. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
Kenyon KW
Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
[TBL] [Abstract][Full Text] [Related]
8. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1.
Levy JH; Mancao MY; Gitter R; Kereiakes DJ; Grigore AM; Aronson S; Newman MF
Anesth Analg; 2007 Oct; 105(4):918-25, table of contents. PubMed ID: 17898366
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients.
Ericsson H; Schwieler J; Lindmark BO; Löfdahl P; Thulin T; Regårdh CG
Chirality; 2001; 13(3):130-4. PubMed ID: 11270321
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion.
Ericsson H; Fakt C; Höglund L; Jolin-Mellgård A; Nordlander M; Sunzel M; Regårdh CG
Eur J Clin Pharmacol; 1999 Mar; 55(1):61-7. PubMed ID: 10206087
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers.
Ericsson H; Bredberg U; Eriksson U; Jolin-Mellgård A; Nordlander M; Regårdh CG
Anesthesiology; 2000 Apr; 92(4):993-1001. PubMed ID: 10754618
[TBL] [Abstract][Full Text] [Related]
12. Clevidipine (Cleviprex) for IV treatment of severe hypertension.
Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023
[No Abstract] [Full Text] [Related]
13. Clevidipine: a new intravenous option for the management of acute hypertension.
Ndefo UA; Erowele GI; Ebiasah R; Green W
Am J Health Syst Pharm; 2010 Mar; 67(5):351-60. PubMed ID: 20172984
[TBL] [Abstract][Full Text] [Related]
14. Clevidipine for controlled hypotension during spinal surgery in adolescents.
Tobias JD; Hoernschemeyer DG
J Neurosurg Anesthesiol; 2011 Oct; 23(4):347-51. PubMed ID: 21623231
[TBL] [Abstract][Full Text] [Related]
15. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial.
Graffagnino C; Bergese S; Love J; Schneider D; Lazaridis C; LaPointe M; Lee K; Lynch G; Hu MY; Williams GC
Cerebrovasc Dis; 2013; 36(3):173-80. PubMed ID: 24135526
[TBL] [Abstract][Full Text] [Related]
16. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension.
Pollack CV; Varon J; Garrison NA; Ebrahimi R; Dunbar L; Peacock WF
Ann Emerg Med; 2009 Mar; 53(3):329-38. PubMed ID: 18534716
[TBL] [Abstract][Full Text] [Related]
17. Clevidipine : a state-of-the-art antihypertensive drug under the scope.
Espina IM; Varon J
Expert Opin Pharmacother; 2012 Feb; 13(3):387-93. PubMed ID: 22251017
[TBL] [Abstract][Full Text] [Related]
18. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans.
Schwieler JH; Ericsson H; Löfdahl P; Thulin T; Kahan T
J Cardiovasc Pharmacol; 1999 Aug; 34(2):268-74. PubMed ID: 10445679
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial.
Singla N; Warltier DC; Gandhi SD; Lumb PD; Sladen RN; Aronson S; Newman MF; Corwin HL;
Anesth Analg; 2008 Jul; 107(1):59-67. PubMed ID: 18635468
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control.
Nordlander M; Sjöquist PO; Ericsson H; Rydén L
Cardiovasc Drug Rev; 2004; 22(3):227-50. PubMed ID: 15492770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
